0001654954-20-001650.txt : 20200214
0001654954-20-001650.hdr.sgml : 20200214
20200214181922
ACCESSION NUMBER: 0001654954-20-001650
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200212
FILED AS OF DATE: 20200214
DATE AS OF CHANGE: 20200214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NIFFENEGGER KATHI
CENTRAL INDEX KEY: 0001620146
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37619
FILM NUMBER: 20622456
MAIL ADDRESS:
STREET 1: C/O STELLAR BIOTECHNOLOGIES, INC.
STREET 2: 332 EAST SCOTT STREET
CITY: PORT HUENEME
STATE: CA
ZIP: 93041
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edesa Biotech, Inc.
CENTRAL INDEX KEY: 0001540159
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
BUSINESS PHONE: (905) 475-1234
MAIL ADDRESS:
STREET 1: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
FORMER COMPANY:
FORMER CONFORMED NAME: Stellar Biotechnologies, Inc.
DATE OF NAME CHANGE: 20120120
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2020-02-12
0001540159
Edesa Biotech, Inc.
EDSA
0001620146
NIFFENEGGER KATHI
C/O EDESA BIOTECH, INC.
100 SPY COURT
MARKHAM
A6
L3R 5H6
ONTARIO, CANADA
true
Chief Financial Officer
Share Option (Right to Buy)
3.16
2020-02-12
4
A
false
88699
0
A
2030-02-12
Common Shares
88699
88699
D
33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested
/s/ Kathi Niffenegger
2020-02-14